Vascular actions of purines in the foetal circulation of the human placenta

作者: M.A. Read , A.L.A. Boura , W.A.W. Walters

DOI: 10.1111/J.1476-5381.1993.TB13832.X

关键词:

摘要: Abstract 1. The vasoactive effects of adenosine triphosphate (ATP), and other purines in the foetal circulation human placenta were examined. Single lobules bilaterally perfused vitro with Krebs buffer (maternal sides 5 ml min-1 each, 95% O2:5% CO2, 37 degrees C). Changes vascular tone assessed by recording perfusion pressure during constant infusion each purine. To allow vasodilator effects, submaximal vasoconstriction was induced concomitant prostaglandin F2 alpha (0.7-2.0 mumol l-1). 2. ATP (1.0-100 l-1) usually caused concentration-dependent reductions pressure. However, biphasic initial transient increases, or only increases sometimes observed. Falls significantly reduced addition to perfusate NG-nitro-L-arginine (L-NOARG) (100 but not NG-nitro-D-arginine (D-NOARG) They influenced indomethacin (10 L-arginine 3. Adenosine (0.01-1.0 mmol consistently pressure, this effect being indomethacin. L-NOARG, D-NOARG, potency approximately three fold. L-Arginine, D-arginine enhanced its a similar amount. 4. 2-Methylthio-ATP, selective P2 gamma agonist 50 times more potent than as agent, always causing decreases pressure.(ABSTRACT TRUNCATED AT 250 WORDS)

参考文章(38)
I H Fox, L Kurpis, Binding characteristics of an adenosine receptor in human placenta. Journal of Biological Chemistry. ,vol. 258, pp. 6952- 6955 ,(1983) , 10.1016/S0021-9258(18)32316-0
H H Oei, A J Hutchison, R L Webb, M B Zimmerman, G R Ghai, M Williams, CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. Journal of Pharmacology and Experimental Therapeutics. ,vol. 251, pp. 47- 55 ,(1989)
A. J. Hutchison, M. A. Sills, R. Schulz, M. F. Jarvis, M. Williams, Un Hoi Do, [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. Journal of Pharmacology and Experimental Therapeutics. ,vol. 251, pp. 888- 893 ,(1989)
G Burnstock, D A Houston, P M Vanhoutte, Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels. Journal of Pharmacology and Experimental Therapeutics. ,vol. 241, pp. 501- 506 ,(1987)
John W. Daly, Adenosine receptors: targets for future drugs Journal of Medicinal Chemistry. ,vol. 25, pp. 197- 207 ,(1982) , 10.1021/JM00345A001
Charles Kennedy, Geoffrey Burnstock, Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein European Journal of Pharmacology. ,vol. 111, pp. 49- 56 ,(1985) , 10.1016/0014-2999(85)90112-8
Terry P. Kenakin, Nicholas B. Pike, An in vitro analysis of purine-mediated renal vasoconstriction in rat isolated kidney. British Journal of Pharmacology. ,vol. 90, pp. 373- 381 ,(1987) , 10.1111/J.1476-5381.1987.TB08967.X
V. Ralevic, R.T. Mathie, B. Alexander, G. Burnstock, Characterization of P2X- and P2Y-purinoceptors in the rabbit hepatic arterial vasculature. British Journal of Pharmacology. ,vol. 103, pp. 1108- 1113 ,(1991) , 10.1111/J.1476-5381.1991.TB12308.X
Jennifer J.I. Mathieson, G. Burnstock, Purine-mediated relaxation and constriction of isolated rabbit mesenteric artery are not endothelium-dependent. European Journal of Pharmacology. ,vol. 118, pp. 221- 229 ,(1985) , 10.1016/0014-2999(85)90132-3